Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | PTGIR | P43119 | 11/20 | 0.47 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6033504 | 0.90 | KMT2A (0.57) | KMT2ALMNAALDH1A1MAPTMEN1 | |
| SCHEMBL6033461 | 0.79 | MAPT (0.39) | KMT2ALMNAALDH1A1MAPTMEN1 | |
| SCHEMBL6033404 | 0.78 | ALDH1A1 (0.41) | KMT2ALMNAALDH1A1MAPTMEN1 | |
| SCHEMBL6032247 | 0.78 | NOS3 (0.35) | KMT2ALMNAALDH1A1MAPTMEN1 | |
| SCHEMBL6032664 | 0.78 | TSHR (0.43) | KMT2ALMNAMAPTMEN1HSD17B10 | |
| SCHEMBL6033318 | 0.78 | SMN1; SMN2 (0.36) | KMT2ALMNAALDH1A1MAPTMEN1 | |
| SCHEMBL6033067 | 0.78 | ALDH1A1 (0.41) | KMT2ALMNAALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL6033133 | 0.77 | PTGIR (0.43) | KMT2ALMNAALDH1A1MAPTMEN1 | |
| SCHEMBL21649530 | 0.72 | MAPT (0.58) | KMT2ALMNAALDH1A1MAPTMEN1 | |
| SCHEMBL6032640 | 0.72 | GFER (0.52) | KMT2ALMNAALDH1A1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7084137-B2 | Thiazines and thiazoles as agents for protecting materials | BAYER AKTIENGESELLSCHAFT (DE) | 2006-08-01 | — | — | US | claimed |
| US-20040204405-A1 | Thiazines and thiazoles as agents for protecting materials | LANXESS DEUTSCHLAND GMBH (DE) | 2004-10-14 | — | — | US | claimed |
| US-20030129081-A1 | Thiazines and thiazoles as agents for protecting materials | BAYER AKTIENGESELLSCHAFT (DE) | 2003-07-10 | — | — | US | claimed |
| US-7084137-B2 | Thiazines and thiazoles as agents for protecting materials | BAYER AKTIENGESELLSCHAFT (DE) | 2006-08-01 | — | — | US | disclosed |
| US-20040204405-A1 | Thiazines and thiazoles as agents for protecting materials | LANXESS DEUTSCHLAND GMBH (DE) | 2004-10-14 | — | — | US | disclosed |
| US-20030129081-A1 | Thiazines and thiazoles as agents for protecting materials | BAYER AKTIENGESELLSCHAFT (DE) | 2003-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030129081-A1 | Thiazines and thiazoles as agents for protecting materials | POT1, NAT1, GPX1 | KMT2A 4152/4885LMNA 1715/4885ALDH1A1 40/4885 |
| US-20040204405-A1 | Thiazines and thiazoles as agents for protecting materials | POT1, NAT1, GPX1 | KMT2A 4152/4885LMNA 1715/4885ALDH1A1 40/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.